BIOLOGICAL FUNCTIONS OF ANGIOGENIN

Mardonov S. Y. & Abdulloyeva H. A.


Annotatsiya

Angiogenesis is a fundamental biological process that plays a critical role in embryonic development, tissue growth, wound healing, and regeneration. It is also involved in various pathological conditions associated with hypoxia and ischemia, including cancer, cardiovascular diseases, and inflammatory disorders. Among the numerous angiogenic factors identified to date, angiogenin is considered one of the most potent and biologically significant regulators of angiogenesis. Angiogenin is a small, secreted protein belonging to the ribonuclease superfamily and is capable of stimulating endothelial cell proliferation, migration, and neovascularization. This article provides a comprehensive review of the molecular structure, biological functions, mechanisms of action, and clinical significance of angiogenin in both physiological and pathological angiogenesis. Understanding the role of angiogenin may contribute to the development of novel diagnostic biomarkers and therapeutic strategies in regenerative medicine and oncology.


Adabiyotlar

  1. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine, 1(1), 27–31.
  2. Li, S., & Hu, G. F. (2012). Emerging role of angiogenin in stress response and cell survival. Biochimica et Biophysica Acta (BBA) – Molecular Cell Research, 1820(5), 662–667.
  3. Tello-Montoliu, A., Patel, J. V., & Lip, G. Y. H. (2006). Angiogenin: A review of the pathophysiology and potential clinical applications. Journal of Thrombosis and Haemostasis, 4(9), 1864–1874.
  4. Hu, G. F. (1998). Neomycin inhibits angiogenin-induced angiogenesis. Proceedings of the National Academy of Sciences, 95(17), 9791–9795.
  5. Kishimoto, K., Liu, S., Tsuji, T., Olson, K. A., & Hu, G. F. (2005). Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene, 24(3), 445–456.
  6. Yoshioka, N., Wang, L., Kishimoto, K., Tsuji, T., & Hu, G. F. (2006). A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proceedings of the National Academy of Sciences, 103(39), 14519–14524.
  7. Gao, X., Xu, Z., & Hu, G. F. (2013). Angiogenin in cancer and cancer therapy. Journal of Molecular Medicine, 91(8), 917–928.
  8. Strydom, D. J. (1998). The angiogenins. Cellular and Molecular Life Sciences, 54(8), 811–824.
  9. Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F., & Vallee, B. L. (1985). Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry, 24(20), 5480–5486.
  10. Olson, K. A., Byers, H. R., Key, M. E., & Fett, J. W. (2002). Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. International Journal of Cancer, 98(6), 923–929.
  11. Xu, Z., & Hu, G. F. (2012). Angiogenin in RNA metabolism and cell survival. Trends in Biochemical Sciences, 37(8), 347–355.
  12. Zhang, J., Li, X., Hu, G. F., & Xu, Z. (2014). Angiogenin mediates estrogen-stimulated breast cancer cell proliferation. Molecular Endocrinology, 28(1), 73–85.
  13. Lee, S. H., & Jeong, D. (2016). Angiogenesis and angiogenic factors in cancer therapy. Oncology Letters, 12(4), 2385–2392.
  14. Carmeliet, P. (2005). Angiogenesis in life, disease and medicine. Nature, 438(7070), 932–936.
  15. Ferrara, N. (2004). Vascular endothelial growth factor: Basic science and clinical progress. Endocrine Reviews, 25(4), 581–611.